Fitzpatrick Alexander A (CIK 0001398595)

Latest company ownership

EVFM - Evofem Biosciences, Inc.
Role: General Counsel and Secretary
Shares held
300,000
Last filed at
Feb 23, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
SPRY - ARS Pharmaceuticals, Inc.
Role: Chief Legal Officer
Shares held
100,000
Last filed at
May 22, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 20, 2025 May 22, 2025 ARS Pharmaceuticals, Inc. Chief Legal Officer Sell 17.5 -102,969 -53.47% ✗ $1.5M
Sep 28, 2023 Oct 2, 2023 ARS Pharmaceuticals, Inc. Chief Legal Officer Buy 97.5 +86,258 2905.29% ✗ $320K
Dec 20, 2021 Dec 20, 2021 Evofem Biosciences, Inc. General Counsel and Secretary Buy 85.0 +25,000 8.03% ✗ $9.7K
Jun 10, 2021 Jun 10, 2021 Evofem Biosciences, Inc. General Counsel and Secretary Buy 83.8 +10,000 3.32% ✗ $10.3K
May 20, 2021 May 21, 2021 Evofem Biosciences, Inc. General Counsel and Secretary Sell 46.3 -42,120 -12.26% ✗ $36.2K
Nov 17, 2020 Nov 18, 2020 Evofem Biosciences, Inc. General Counsel and Secretary Buy 86.3 +9,090 6.76% ✗ $20K
Jun 5, 2020 Jun 8, 2020 Evofem Biosciences, Inc. General Counsel and Secretary Sell 42.5 -31,590 -19.03% ✗ $104.6K
May 22, 2020 May 26, 2020 Evofem Biosciences, Inc. General Counsel and Secretary Sell 42.5 -39,487 -19.21% ✗ $197K
May 6, 2020 May 8, 2020 Evofem Biosciences, Inc. General Counsel and Secretary Sell 46.3 -7,802 -3.66% ✗ $40.9K
Nov 25, 2019 Nov 26, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 46.3 -7,747 -10.90% ✗ $48.2K
Nov 20, 2019 Nov 21, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 46.3 -7,747 -9.83% ✗ $44.5K
Oct 16, 2019 Oct 17, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 42.5 -18,427 -18.95% ✗ $92.3K
Aug 22, 2019 Aug 26, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 47.5 -1,296 -1.32% ✗ $6.6K
Jun 10, 2019 Jun 12, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 46.3 -7,777 -7.31% ✗ $49.5K
Apr 1, 2019 Apr 3, 2019 Evofem Biosciences, Inc. General Counsel and Secretary Sell 47.5 -1,298 -1.21% ✗ $4.6K
Oct 16, 2018 Oct 17, 2018 Evofem Biosciences, Inc. General Counsel and Secretary Sell 42.5 -17,377 -23.17% ✗ $65.7K
Aug 20, 2018 Aug 21, 2018 Evofem Biosciences, Inc. General Counsel and Secretary Buy 86.3 +5,000 7.14% ✗ $11K